Teva Pharmaceutical reported $55M in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Aspen Pharmacare APN:SJ ZAR 3.13B 232M
Cipla CIPLA:IN INR 7.89B 1.03B
Dr.Reddys Laboratories DRRD:IN INR 11.14B 748M
Guangzhou Baiy 600332:CH CNY 884.37M 100.02M
Jiangsu Hengrui Me. 600276:CH CNY 1.05B 171.68M
Kalbe Farma Tbk Pt KLBF:IJ IDR 848.57B 46.5B
Richter Gedeon RICHT:HB HUF 82.42B 5.89B
Sh Fosun Pharma 600196:CH CNY 907.03M 177.79M
Sun Pharmaceuticals SUNP:IN INR 22.62B 2.01B
Teva Pharmaceutical TEVA:IT USD 55M 288M